Abstract:Pediatric obesity is a chronic and growing problem for which new ideas about the biologic basis of obesity offer hope for effective solutions. Prevalence of pediatric and adult obesity is increasing despite a bewildering array of treatment programs and severe psychosocial and economic costs. The definition of obesity as an increase in fat mass, not just an increase in body weight, has profound influence on the understanding and treatment of obesity. In principle, body weight is determined by a balance between energy expenditure and energy intake, but this observation does not by itself explain obesity. There is surprisingly little evidence that the obese overeat and only some evidence that the obese are more sedentary. Understanding of the biologic basis of obesity has grown rapidly in the last few years, especially with the identification of a novel endocrine pathway involving the adipose tissue secreted hormone leptin and the leptin receptor that is expressed in the hypothalamus. Plasma leptin levels are strongly correlated with body fat mass and are regulated by feeding and fasting, insulin, glucocorticoids, and other factors, consistent with the hypothesis that leptin is involved in body weight regulation and may even be a satiety factor (Fig. 2, Table 1). Leptin injections have been shown to reduce body weight of primates, although human clinical trials will not be reported until summer 1997. So many peptides influencing feeding have been described that one or more may have therapeutic potential (Fig. 2, Table 1). Although the complexity of pathways regulating body weight homeostasis slowed the pace of understanding underlying mechanisms, these complexities now offer many possibilities for novel therapeutic interventions (Fig. 2). Obesity is a major risk factor for insulin resistance and diabetes, hypertension, cancer, gallbladder disease, and atherosclerosis. In particular, adults who were obese as children have increased mortality independent of adult weight. Thus, prevention programs for children and adolescents will have long-term benefits. Treatment programs focus on modification of energy intake and expenditure through decreased calorie intake and exercise programs. Behavior-modification programs have been developed to increase effectiveness of these intake and exercise programs. These programs can produce short-term weight loss. Long-term losses are more modest but achieved more successfully in children than in adults. Several drug therapies for obesity treatment recently have been approved for adults that produce sustained 5% to 10% weight losses but experience with their use in children is limited. Identification of the biochemical pathways causing obesity by genetic approaches could provide the theoretic foundation for novel, safe, and effective obesity treatments. The cloning of leptin in 1994 has already led to testing the efficacy of leptin in clinical trials that are now underway. Although novel treatments of obesity are being developed as a result of the new biology of obesity, prevention of obesity remains an important goal.

Time for a new framework that treats obesity in children as an adiposity-based chronic disease

Diagnosis of obesity based on body composition‐associated health risks—Time for a change in paradigm

Global, Regional, and National Prevalence of Overweight and Obesity in Children and Adults During 1980-2013: A Systematic Analysis for the Global Burden of Disease Study 2013

Anti‐Obesity Medication in the Management of Children and Adolescents With Obesity: Recent Developments and Research Gaps

Childhood and Adolescent Obesity: A Review

Pediatric obesity. An overview of etiology and treatment

Management of Childhood Obesity—Time to Shift from Generalized to Personalized Intervention Strategies

Conference on ‘ Childhood nutrition and obesity : current status and future challenges ’ Symposium 4 : Strategies for reducing childhood obesity Management of obesity in children differs from that of adults

Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity

Overview of Pediatric Obesity as a Disease

A clinician's guide to effects of obesity on childhood asthma and into adulthood

Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for Ireland

Enough with simplifying: "eat less and move more": at what point are we with the treatment of excess weight in paediatrics?

Obesity management in the pediatric patient

Obesity – Standards, trends and advances

Pediatric Obesity Pharmacotherapy: State of the Science, Research Gaps, and Opportunities

Obesity class versus the Edmonton Obesity Staging System for Pediatrics to define health risk in childhood obesity: results from the CANPWR cross-sectional study

Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification

Weighing the future: strategic measures against rising childhood obesity

Optimizing Childhood Obesity Management: The Role of Edmonton Obesity Staging System in Personalized Care Pathways

Adult obesity treatment and prevention: A trans‐agency commentary on the research landscape, gaps, and future opportunities